990TiPPhase III LEAP-011 trial: First-line pembrolizumab...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

990TiPPhase III LEAP-011 trial: First-line pembrolizumab with lenvatinib in patients with advanced urothelial carcinoma ineligible to receive platinum-based chemotherapy

Loriot, Y, Balar, A, de Wit, R, Garcia, J A, Grivas, P, Matsubara, N, Frenkl, T L, Sbar, E, Jia, X C, Fouad, T, Siefker-Radtke, A O
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.086
Date:
October, 2019
File:
PDF, 84 KB
2019
Conversion to is in progress
Conversion to is failed